Europe Warts Therapeuctis Market
The Europe Warts Therapeuctis Market size was valued at US$ 538.1 Mn in 2021 and is projected to reach US$ 667.6 Mn by 2028, growing at a CAGR of 3.1% during 2021 - 2028.
Report Coverage
- Type: Common Warts, Genital Warts, Flat Warts
- Treatment: Physical Destruction, Immunomodulation, Chemical Destruction
- End User: Hospitals, Homecare, Specialty Clinics
US$ 538.1 Mn
Market size in 2021
US$ 667.6 Mn
Market Size by 2028
3.1%
CAGR, 2021 - 2028
2022-2028
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Warts Therapeuctis Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Warts Therapeuctis Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Warts Therapeuctis Market Regional Analysis
6.2 Europe Warts Therapeuctis Market Revenue 2019-2028 (US$ Million)
6.3 Europe Warts Therapeuctis Market Forecast Analysis
7. Europe Warts Therapeuctis Market Analysis – by Type
7.1 Common Warts
- 7.1.1 Overview
- 7.1.2 Common Warts: Europe Warts Therapeuctis Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Genital Warts
- 7.2.1 Overview
- 7.2.2 Genital Warts: Europe Warts Therapeuctis Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Flat Warts
- 7.3.1 Overview
- 7.3.2 Flat Warts: Europe Warts Therapeuctis Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. Europe Warts Therapeuctis Market Analysis – by Treatment
8.1 Physical Destruction
- 8.1.1 Overview
- 8.1.2 Physical Destruction: Europe Warts Therapeuctis Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Immunomodulation
- 8.2.1 Overview
- 8.2.2 Immunomodulation: Europe Warts Therapeuctis Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.3 Chemical Destruction
- 8.3.1 Overview
- 8.3.2 Chemical Destruction: Europe Warts Therapeuctis Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. Europe Warts Therapeuctis Market Analysis – by End User
9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: Europe Warts Therapeuctis Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.2 Homecare
- 9.2.1 Overview
- 9.2.2 Homecare: Europe Warts Therapeuctis Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.3 Specialty Clinics
- 9.3.1 Overview
- 9.3.2 Specialty Clinics: Europe Warts Therapeuctis Market – Revenue and Forecast, 2019-2028 (US$ Million)
10. Europe Warts Therapeuctis Market – Europe Analysis
10.1 Overview
10.2 Europe- 10.2.1 Europe Warts Therapeuctis Market Breakdown, by Key Country, 2022 and 2028 (%)
- 10.2.1.1 Europe Warts Therapeuctis Market – Revenue and Forecast Analysis – by Country
- 10.2.1.1 UK: Europe Warts Therapeuctis Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.1.1 UK: Europe Warts Therapeuctis Market Breakdown, by Type
- 10.2.1.1.2 UK: Europe Warts Therapeuctis Market Breakdown, by Treatment
- 10.2.1.1.3 UK: Europe Warts Therapeuctis Market Breakdown, by End User
- 10.2.1.2 Germany: Europe Warts Therapeuctis Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.2.1 Germany: Europe Warts Therapeuctis Market Breakdown, by Type
- 10.2.1.2.2 Germany: Europe Warts Therapeuctis Market Breakdown, by Treatment
- 10.2.1.2.3 Germany: Europe Warts Therapeuctis Market Breakdown, by End User
- 10.2.1.3 France: Europe Warts Therapeuctis Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.3.1 France: Europe Warts Therapeuctis Market Breakdown, by Type
- 10.2.1.3.2 France: Europe Warts Therapeuctis Market Breakdown, by Treatment
- 10.2.1.3.3 France: Europe Warts Therapeuctis Market Breakdown, by End User
- 10.2.1.4 Russia: Europe Warts Therapeuctis Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.4.1 Russia: Europe Warts Therapeuctis Market Breakdown, by Type
- 10.2.1.4.2 Russia: Europe Warts Therapeuctis Market Breakdown, by Treatment
- 10.2.1.4.3 Russia: Europe Warts Therapeuctis Market Breakdown, by End User
- 10.2.1.5 Italy: Europe Warts Therapeuctis Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.5.1 Italy: Europe Warts Therapeuctis Market Breakdown, by Type
- 10.2.1.5.2 Italy: Europe Warts Therapeuctis Market Breakdown, by Treatment
- 10.2.1.5.3 Italy: Europe Warts Therapeuctis Market Breakdown, by End User
- 10.2.1.6 Rest of Europe: Europe Warts Therapeuctis Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.6.1 Rest of Europe: Europe Warts Therapeuctis Market Breakdown, by Type
- 10.2.1.6.2 Rest of Europe: Europe Warts Therapeuctis Market Breakdown, by Treatment
- 10.2.1.6.3 Rest of Europe: Europe Warts Therapeuctis Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Bausch Health Companies Inc.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Euro Vital Pharma GmbH
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Cipla Inc.
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Koninklijke Utermöhlen NV
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Scholl's Wellness Company
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Teva Pharmaceutical Industries Ltd
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 GlaxoSmithKline plc.
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 AIM ImmunoTech Inc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Access the Full E Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
